tiprankstipranks
Trending News
More News >
BeOne Medicines (ONC)
NASDAQ:ONC
US Market

BeOne Medicines (ONC) Income Statement

Compare
859 Followers

BeOne Medicines Income Statement

Last quarter (Q4 2025), BeOne Medicines's total revenue was $1.50B, an increase of 32.84% from the same quarter last year. In Q4, BeOne Medicines's net income was $66.50M. See BeOne Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.34B$ 3.81B$ 2.46B$ 1.42B$ 1.18B
Gross Profit
$ 4.67B$ 3.22B$ 2.08B$ 1.13B$ 1.01B
Operating Expenses
$ 4.23B$ 3.78B$ 3.29B$ 2.92B$ 2.45B
Depreciation and Amortization
$ 141.69M$ 171.76M$ 87.67M$ 66.28M$ 46.46M
EBITDA
$ 616.77M$ -396.44M$ -1.12B$ -1.72B$ -1.39B
Operating Income
$ 447.14M$ -568.20M$ -1.21B$ -1.79B$ -1.44B
Other Income/Expenses
$ -30.28M$ 35.20M$ 381.90M$ -171.37M$ 147.00K
Pretax Income
$ 416.85M$ -533.00M$ -825.84M$ -1.96B$ -1.44B
Net Income
$ 286.93M$ -644.79M$ -881.71M$ -2.00B$ -1.46B
Per Share Metrics
Basic EPS
$ 34.19$ -6.12$ -8.45$ -19.37$ -15.21
Diluted EPS
$ 32.89$ -6.12$ -8.45$ -19.37$ -15.21
Weighted Average Shares Outstanding
109.06M 105.29M 104.39M 103.13M 92.79M
Weighted Average Shares Outstanding (Diluted)
113.45M 105.29M 104.39M 103.13M 92.79M
Currency in USD

BeOne Medicines Earnings and Revenue History